Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...

Non-Alcoholic Fatty Liver Disease (NAFLD) is emerging as a significant global health concern, driven by increasing rates of obesity, diabetes and sedentary lifestyles. NAFLD includes a spectrum of ...

NAFLD comprises a pathological spectrum characterized by fat accumulation within the liver known as simple steatosis, or "non-NASH NAFLD," and/or in combination with varying degrees of ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions worldwide. This complex ...

Conclusion: SteatoTest is a simple and non-invasive quantitative estimate of liver steatosis and may reduce the need for liver biopsy, particularly in patients with metabolic risk factor.